NLRP3 and ischemic stroke: However, meisoindigo (3,30-linked bisindole, a second-generation derivative of indirubin) may inhibit the activation of NLRP3 inflammasomes and M1 polarization by inhibiting the TLR/NFκB signaling pathway, and it is expected to become a new drug for the treatment of ischemic stroke [146].